345 related articles for article (PubMed ID: 20151980)
21. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic growth factors in drug-induced agranulocytosis.
Pavithran K; Thomas M
J Assoc Physicians India; 2002 May; 50(5):679-81. PubMed ID: 12186123
[TBL] [Abstract][Full Text] [Related]
24. Recovery of carbimazole-induced agranulocytosis following recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration.
Meletis J; Vavourakis S; Andreopoulos T; Yataganas X; Poziopoulos C; Lafioniatis S; Konstantopoulos K; Loukopoulos D
Haematologica; 1993; 78(5):329-31. PubMed ID: 8314163
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Okamura S; Morita M; Tamaru M; Murakami N; Niho Y
Arch Intern Med; 1993 Feb; 153(4):509-14. PubMed ID: 7679571
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
27. [Drug-induced agranulocytosis: clinical study of 19 cases].
Márquez JA; Pardo C; Amutio E; Cortés C; Piñán MA; Alvarez C
Sangre (Barc); 1998 Oct; 43(5):436-8. PubMed ID: 9868339
[TBL] [Abstract][Full Text] [Related]
28. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
Lehrnbecher T
Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
[TBL] [Abstract][Full Text] [Related]
29. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
30. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
Gullion G; Yeh HS
J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
[TBL] [Abstract][Full Text] [Related]
31. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on neutrophil formation and function.
Khwaja A; Linch DC
Curr Opin Hematol; 1994 May; 1(3):216-20. PubMed ID: 9371285
[TBL] [Abstract][Full Text] [Related]
32. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
[TBL] [Abstract][Full Text] [Related]
33. [GM-CSF.G-CSF].
Kitamura K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):301-5. PubMed ID: 7531964
[TBL] [Abstract][Full Text] [Related]
34. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
Lally J; Malik S; Whiskey E; Taylor DM; Gaughran FP; Krivoy A; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Aug; 37(4):441-446. PubMed ID: 28437295
[TBL] [Abstract][Full Text] [Related]
35. Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature.
Andrès E; Kurtz JE; Maloisel F
Clin Lab Haematol; 2002 Apr; 24(2):99-106. PubMed ID: 11985555
[TBL] [Abstract][Full Text] [Related]
36. Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor.
Roddie P; Dorrance H; Cook MK; Rainey JB
Aliment Pharmacol Ther; 1995 Dec; 9(6):711-2. PubMed ID: 8824661
[TBL] [Abstract][Full Text] [Related]
37. Non-chemotherapy drug-induced agranulocytosis.
Garbe E
Expert Opin Drug Saf; 2007 May; 6(3):323-35. PubMed ID: 17480181
[TBL] [Abstract][Full Text] [Related]
38. Haematologic effects of granulocyte-macrophage colony stimulating factor in a patient with thiamazole-induced agranulocytosis.
Björkholm M; Pisa P; Arver S; Beran M
J Intern Med; 1992 Nov; 232(5):443-5. PubMed ID: 1453130
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte-colony stimulating factor for sulfasalazine-induced agranulocytosis.
Gales BJ; Gales MA
Ann Pharmacother; 1993 Sep; 27(9):1052-4. PubMed ID: 7693069
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study.
Fukata S; Kuma K; Sugawara M
Thyroid; 1999 Jan; 9(1):29-31. PubMed ID: 10037073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
